Social impact of preventive HIV vaccine clinical trial participation: A model of prevention, assessment and intervention

Social Science and Medicine

Volumn 66, Issue 4, 2008, Pages 945-951

  Allen, Mary ^a   Lau, Chuen Yen ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Clinical trial; HIV vaccine; NIAID; Social harm; Social impact; USA

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

HEALTH EDUCATION; HUMAN IMMUNODEFICIENCY VIRUS; LOCAL PARTICIPATION; MODEL; NONGOVERNMENTAL ORGANIZATION; SOCIAL IMPACT; VACCINATION;

ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; HEALTH CARE ORGANIZATION; HEALTH EDUCATION; HEALTH INSURANCE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; RISK FACTOR; WESTERN BLOTTING;

AIDS VACCINES; CLINICAL TRIALS AS TOPIC; HIV INFECTIONS; HUMANS; PREJUDICE; SOCIAL ENVIRONMENT; SOCIAL SUPPORT;

NORTH AMERICA; UNITED STATES;

EID: 38749124788     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2007.10.019     Document Type: Article

References (9)

1. Allen M., Israel H., Rybczyk K., Pugliese M.A., Loughran K., Wagner L., et al. Trial-related discrimination in HIV vaccine clinical trials. AIDS Research and Human Retroviruses 18 (2001) 667-674
2. Belshe R.B., Clements M.L., Keefer M.C., Graham B.S., Corey L., Sposto R., et al. Interpreting HIV serodiagnostic test results in the 1990's: social risks of HIV vaccine studies in uninfected volunteers. Annals of Internal Medicine 121 (1994) 584-589
3. Buchbinder S.P., Metch B., Holte S.E., Scheer S., Coletti A., and Vittinghoff E. Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation. Journal of Acquired Immune Deficiency Syndrome 36 (2004) 604-612
4. Frey S.E. Unique risks to volunteers in HIV vaccine trials. Journal of Investigative Medicine 51 Suppl. 1 (2003) S18-S20
5. Grady C. The search for an AIDS vaccine: Ethical issues in the development and testing of a preventive HIV vaccine (1995), Indiana University Press, Bloomington, Indiana
6. Newman P.A., Duan N., Rudy E.T., and Anton P.A. Challenges for HIV vaccine dissemination and clinical trial recruitment: if we build it, will they come?. AIDS Patient Care 18 (2004) 691-701
7. Paxton S., Gonzales G., Uppakaew K., Abraham K.K., Okta S., Green C., et al. AIDS-related discrimination in Asia. AIDS Care 17 (2005) 413-424
8. Sullivan, P., Rossini, T., deBruyn, G., Chiu, Y., Belshe, R., et al. Positive HIV serology results induced by vaccine among participants in 10 clinical trials of canarypox-vectored HIV vaccine trial units in the US. Poster presented at the 2006 Conference on Retroviruses and Opportunistic Infections, February 7, 2006. Available from . Accessed 04.06.07.
9. Temoshok L.R. Behavioral research contributions to planning and conducting HIV vaccine efficacy studies. AIDS Research and Human Retroviruses 10 (1994) S277-S280